On-demand Webinar I Characterizing Antibody-Drug Conjugates (ADCs) Through Innovative Analytical Solutions

Reducing time to market for ADCs requires early adoption of analytical methods that deliver high-confidence data across development stages. Join experts from Phenomenex and SCIEX, Life Sciences companies of Danaher, to explore the integrated workflows designed to:

• Characterize intact ADCs with native LC-MS to quickly detect structural variants and aggregation

• Quantify DAR and resolve isomer profiles using Biozen Native RP columns under native conditions

• Assess charge heterogeneity and conjugation sites using the Intabio ZT system (icIEF-UV/MS) and EAD peptide mapping

As modalities evolve, your analytical strategy must keep up. Our flexible, scalable solutions grow with your pipelin - from discovery to delivery.